Vivalink Advocates for Continuous Safety Monitoring in AI-Enabled Early-Phase Clinical Trials Pilot
2026-07-03
PubComNonGov2026-07-03
Carter Struck
WASHINGTON, July 3 -- Vivalink Inc., Hayward, California, provided a comprehensive public comment letter to the U.S. Food and Drug Administration concerning the AI-Enabled Optimization of Early-Phase . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 3 -- Vivalink Inc., Hayward, California, provided a comprehensive public comment letter to the U.S. Food and Drug Administration concerning the AI-Enabled Optimization of Early-Phase . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026